Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Effect of marathon running on total and free serum prostate-specific antigen concentrations.

Kratz A, Lewandrowski KB, Siegel AJ, Sluss PM, Chun KY, Flood JG, Lee-Lewandrowski E.

Arch Pathol Lab Med. 2003 Mar;127(3):345-8.

PMID:
12653581
[PubMed - indexed for MEDLINE]
2.

[Prostate cancer].

Uchida K, Akaza H.

Gan To Kagaku Ryoho. 2001 Oct;28(10):1469-74. Review. Japanese.

PMID:
11681260
[PubMed - indexed for MEDLINE]
3.

[Prostate-specific antigen as a tumor marker of prostate carcinoma].

Wymenga LF, Mensink HJ.

Ned Tijdschr Geneeskd. 1999 Aug 21;143(34):1733-8. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd 1999 Oct 9;143(41):2080.

PMID:
10494319
[PubMed - indexed for MEDLINE]
4.

Prognostic value of serum markers for prostate cancer.

Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.

Scand J Urol Nephrol Suppl. 2005 May;(216):64-81. Review.

PMID:
16019759
[PubMed - indexed for MEDLINE]
5.

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.

Recker F, Kwiatkowski MK, Piironen T, Pettersson K, L├╝mmen G, Wernli M, Wiefelsp├╝tz J, Graber SF, Goepel M, Huber A, Tscholl R.

Cancer. 1998 Dec 15;83(12):2540-7.

PMID:
9874461
[PubMed - indexed for MEDLINE]
6.

Individual prostate-specific antigen (PSA) forms as prostate tumor markers.

Becker C, Lilja H.

Clin Chim Acta. 1997 Jan 3;257(1):117-32. Review.

PMID:
9028629
[PubMed - indexed for MEDLINE]
7.

Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.

Huncharek M, Muscat J.

Abdom Imaging. 1996 Jul-Aug;21(4):364-7.

PMID:
8661585
[PubMed - indexed for MEDLINE]
8.

Recreational and master athletic activity does not affect free and total prostate-specific antigen levels but lowers the free-to-total prostate-specific antigen ratio.

Ulman C, Buyukyazi G, Taneli F, Uyanik BS.

J Int Med Res. 2004 Nov-Dec;32(6):583-9.

PMID:
15587752
[PubMed - indexed for MEDLINE]
9.

[Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].

Haese A, Graefen M, Palisaar J, Huland E, Huland H.

Urologe A. 2003 Sep;42(9):1172-87. Review. German.

PMID:
14504750
[PubMed - indexed for MEDLINE]
10.

Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostate cancer.

Ellis WJ, Etzioni R, Vessella RL, Hu C, Goodman GE.

J Urol. 2001 Jul;166(1):93-8; discussion 98-9.

PMID:
11435831
[PubMed - indexed for MEDLINE]
11.

Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.

Suzuki H, Akakura K, Igarashi T, Ueda T, Ito H, Watanabe M, Nomura F, Ochiai T, Shimada H.

J Urol. 2004 Jan;171(1):182-6.

PMID:
14665872
[PubMed - indexed for MEDLINE]
12.

Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?

Wolff JM, Zimny M, Borchers H, Wildberger J, Buell U, Jakse G.

Eur Urol. 1998;33(4):376-81.

PMID:
9612680
[PubMed - indexed for MEDLINE]
13.

[Prostate-specific antigen].

Eide IA, Angelsen A.

Tidsskr Nor Laegeforen. 2000 Sep 10;120(21):2528-31. Review. Norwegian.

PMID:
11070990
[PubMed - indexed for MEDLINE]
14.

Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen.

Nixon RG, Lilly JD, Liedtke RJ, Batjer JD.

Arch Pathol Lab Med. 1997 Apr;121(4):385-91.

PMID:
9140308
[PubMed - indexed for MEDLINE]
15.

The value of the ratio of free-to-total prostate specific antigen for staging purposes in previously untreated prostate cancer.

Noldus J, Graefen M, Huland E, Busch C, Hammerer P, Huland H.

J Urol. 1998 Jun;159(6):2004-7; discussion 2007-8.

PMID:
9598507
[PubMed - indexed for MEDLINE]
16.

[Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].

Nutahara K, Higashihara E.

Rinsho Byori. 2001 Oct;49(10):963-6. Japanese.

PMID:
11769472
[PubMed - indexed for MEDLINE]
17.

[Advanced prostate cancer with normal serum prostate-specific antigen values].

Komura T, Yamagiwa K, Ogura H, Kohjimoto Y, Ohkawa T, Inagaki T, Ebisuno S, Senzaki A.

Hinyokika Kiyo. 1998 May;44(5):303-6. Japanese.

PMID:
9656099
[PubMed - indexed for MEDLINE]
19.

[Significance of the PSA-concentration for the detection of prostate cancer].

Stachon A.

Pathologe. 2005 Nov;26(6):469-72. German.

PMID:
16195861
[PubMed - indexed for MEDLINE]
20.

Prostate specific antigen as tumor marker: relationship with histologic grading.

Xess A, Singh M, Raghwendra KH, Sharma HP, Shahi SK.

Indian J Pathol Microbiol. 2001 Jul;44(3):261-4.

PMID:
12024909
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk